Characteristics and Requirements of Pharmacoepidemiologic Safety Studies Using Electronic Healthcare Databases

Tian-tian ZHU,Xiao-fei YE,Xiao-jing GUO,Tian-yi ZHANG,Jing WANG,Wen-tao SHI,Jia HE
DOI: https://doi.org/10.3969/j.issn.1672-8629.2014.07.007
2014-01-01
Abstract:Pharmacoepidemiologic studies play an important role in evaluating the interrelationship between drugs and adverse events. With the development of the electronic healthcare databases, the traditional method of pharmacoepi-demiologic study cannot completely meet the needs of the pharmacovigilance today. Based on the understanding of the electronic healthcare databases and of the FDA related guidelines, this paper proposes to introduce the general char-acteristics of pharmacoepidemiologic safety studies using electronic healthcare databases and the requirements of the data collection put forward by FDA, which aims to provide relevant technical reference to our country's pharma coepi-demiologic studies and pharmacovigilance.
What problem does this paper attempt to address?